Floatz logo

Bxcl501

Respiratory Function

Ruijin HospitalPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Respiratory Function cohort.

Asset / SponsorPhaseRating
NEOSTIGMINE
Ziekenhuis Oost-Limburg
Phase 4BB
Rocuronium
Ziekenhuis Oost-Limburg
Phase 4BB
Glycopyrrolate
Ziekenhuis Oost-Limburg
Phase 4BB
.GAMMA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,7F,6G,6H-OCTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,7F,6G,6H-OCTATHIO-
Ziekenhuis Oost-Limburg
Phase 4BB
Atropine
Ruijin Hospital
Phase 2CCC
Hyoscine
Ruijin Hospital
Phase 2CCC
Compound Edaravone
Ruijin Hospital
Phase 2CCC

Same molecule, other indications

Bxcl501 is also rated in:

Pain, ChronicDormant
A
Indicative ·
80 / 100
View asset →
Agitation,PsychomotorDormant
A
Indicative ·
80 / 100
View asset →
schizophreniform disorderDormant
A
Indicative ·
80 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →